For further details see:
Abbott Q1 results highlights pressure on COVID-19 test makers as vaccinations ramp upFor further details see:
Abbott Q1 results highlights pressure on COVID-19 test makers as vaccinations ramp upMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
2024-08-02 04:10:00 ET Pfizer (NYSE: PFE) is one of the most successful pharmaceutical companies ever. In 2022, it brought in more than $100 billion in revenue -- a record for itself and for the entire industry. Of course, a lot of this was due to an unprecedented situation -- the C...
2024-08-01 05:50:00 ET Pfizer (NYSE: PFE) has been a nightmare for many investors in recent years. At one point earlier this year, the big pharma stock was nearly 60% below its peak set in late 2021. However, the narrative for Pfizer appears to be changing. Its shares are up a r...
2024-08-01 04:20:00 ET The anti-obesity drug market could be worth a staggering $100 billion, according to some analysts. That's a huge growth opportunity, and it's a reason why many top drugmakers in the world are spending feverishly on new weight loss drugs, as they know it could pr...